Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.61 |
| ▸ | CTSB | P07858 | 2/20 | 0.58 |
| ▸ | CTSK | P43235 | 2/20 | 0.58 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.57 |
| ▸ | NPY1R | P25929 | 3/20 | 0.57 |
| ▸ | NPY2R | P49146 | 3/20 | 0.57 |
| ▸ | NPY4R | P50391 | 3/20 | 0.57 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.57 |
| ▸ | GHSR | Q92847 | 1/20 | 0.56 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573751 | 0.90 | NPY1R (0.60) | KISS1RCTSBCTSKNPBWR1NPY1R | |
| SCHEMBL29683439 | 0.89 | NPBWR1 (0.59) | KISS1RCTSBCTSKNPBWR1MAGI3 | |
| SCHEMBL30378939 | 0.87 | PTH1R (0.60) | KISS1RNPY2RGHSRMAGI3IL23R | |
| Kqikiwfqnkkmkwkk-Nh2 SCHEMBL31748869 | 0.86 | PTH1R (0.60) | GHSRIL23R | |
| SCHEMBL29417894 | 0.86 | NPBWR1 (0.59) | CTSBCTSKNPBWR1 | |
| SCHEMBL29589176 | 0.86 | NPY1R (0.62) | CTSBCTSKNPBWR1NPY1RNPY2R | |
| SCHEMBL29471300 | 0.85 | CTSB (0.60) | CTSBCTSKNPBWR1NPY1RNPY2R | |
| SCHEMBL25549782 | 0.85 | GHSR (0.59) | KISS1RGHSRMAGI3IL23R | |
| SCHEMBL27913477 | 0.84 | EDNRA (0.59) | KISS1RPCSK9 | |
| SCHEMBL27913484 | 0.84 | EDNRA (0.59) | KISS1RPCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287190-A1 | BISPECIFIC MOLECULE SPECIFICALLY BINDING TO B7-H3 AND TGFB AND USES THEREOF | THERANOTICS CO., LTD. (KR) | 2024-08-29 | — | — | US | claimed |
| EP-4393953-A1 | BISPECIFIC MOLECULE SPECIFICALLY BINDING TO B7-H3 AND TGF? AND USES THEREOF | Theranotics Co., Ltd. (KR) | 2024-07-03 | — | — | EP | claimed |
| US-20240158505-A1 | B7-H3 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF | THERANOTICS CO., LTD. (KR) | 2024-05-16 | — | — | US | claimed |
| EP-4231079-A1 | PHOTOGRAPHING LENS SYSTEM, IMAGE CAPTURING UNIT AND ELECTRONIC DEVICE | Largan Precision Co. Ltd. (TW) | 2023-08-23 | — | — | EP | claimed |
| US-11641771-B2 | Electro-optical device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2023-05-02 | — | — | US | claimed |
| WO-2023027561-A1 | BISPECIFIC MOLECULE SPECIFICALLY BINDING TO B7-H3 AND TGFΒ AND USES THEREOF | 세라노틱스(주) | 2023-03-02 | — | — | WO | claimed |
| US-20230016045-A1 | WIDEBAND DUAL POLARIZED HOURGLASS SHAPED WITH WEDGE ANTENNA FOR 3G/4G/5G BASE STATION ANTENNA | VIETTEL GROUP (VN) | 2023-01-19 | — | — | US | claimed |
| WO-2022203414-A1 | B7-H3 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF | 세라노틱스(주) | 2022-09-29 | — | — | WO | claimed |
| US-20260145674-A1 | VEHICLE CONTROL APPARATUS AND PROGRAM | DENSO CORPORATION (JP) | 2026-05-28 | — | — | US | disclosed |
| US-20260044041-A1 | DISPLAY DEVICE | LG ELECTRONICS INC. (KR) | 2026-02-12 | — | — | US | disclosed |
| US-12544389-B2 | Stable cannabinoid formulations | FRESH CUT DEVELOPMENT, LLC (CA) | 2026-02-10 | — | — | US | disclosed |
| EP-4680204-A1 | CANNABINOID FORMULATIONS | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680205-A1 | CANNABINOID FORMULATIONS | DSM IP Assets B.V. (NL) | 2026-01-21 | — | — | EP | disclosed |
| EP-3302437-B2 | STABLE CANNABINOID FORMULATIONS | FRESH CUT DEV LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| CN-109475584-B | Lactic acid bacteria composition for the treatment of bacterial vaginal infections and possible concurrent fungal infections caused by Gardnerella vaginalis | 波比奥泰克股份公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114222754-A | Botulinum toxin type A complexes, formulations and methods of use thereof | 台湾浩鼎生技股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-20220082878-A1 | DRIVER CIRCUIT AND DISPLAY PANEL | HKC Corporation Limited (CN) | 2022-03-17 | — | — | US | disclosed |
| CN-216054684-U | Semiconductor device, lead frame and power supply device | 新电元工业株式会社 | 2022-03-15 | — | — | CN | disclosed |
| WO-2022044243-A1 | TRAINING DEVICE, INFERENCE DEVICE, METHODS THEREFOR, AND PROGRAM | 日本電信電話株式会社 | 2022-03-03 | — | — | WO | disclosed |
| US-11249939-B2 | Methods and apparatus for sharing nodes in a network with connections based on 1 to k+1 adjacency used in an execution array memory array (XarMa) processor | PECHANEK GERALD GEORGE (US) | 2022-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260145674-A1 | VEHICLE CONTROL APPARATUS AND PROGRAM | COG2, CDR2, USE1 | KISS1R 4665/4885CTSB 3005/4885CTSK 3370/4885 |
| US-20260044041-A1 | DISPLAY DEVICE | JUND, CFD, MAP2K4 | KISS1R 1648/4885CTSB 630/4885CTSK 1014/4885 |
| US-12544389-B2 | Stable cannabinoid formulations | CNR2, CNR1, DEGS1 | KISS1R 1636/4885CTSB 1893/4885CTSK 2016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.